Clinical Therapeutics

A review of combined hepatitis A and hepatitis B vaccination for travelers
pp. 2337-2351(15)
Author: Spira A.M.

Pharmacology and therapeutics of ezetimibe (SCH 58235), a cholesterol-absorption inhibitor
pp. 2352-2387(36)
Authors: Jeu L.; Cheng J.W.M.

Long-term safety and efficacy of the selective aldosterone blocker eplerenone in patients with essential hypertension
pp. 2388-2404(17)
Authors: Burgess E.D.; Lacourciere Y.; Ruilope-Urioste L.M.; Oparil S.; Kleiman J.H.; Krause S.; Roniker B.; Maurath C.

An open-label, prospective, observational study of the incidence of coronary artery disease in patients with hiv infection receiving highly active antiretroviral therapy
pp. 2405-2418(14)
Authors: Barbaro G.; Lorenzo G.D.; Cirelli A.; Grisorio B.; Lucchini A.; Hazra C.; Barbarini G.

Association between antibiotic prescribing and visit duration in adults with upper respiratory tract infections
pp. 2419-2430(12)
Authors: Linder J.A.; Singer D.E.; Stafford R.S.

A retrospective analysis of the effect of noncompliance on time to first major adverse cardiac event in LIPS
pp. 2431-2447(17)
Authors: Lesaffre E.; Kocmanova D.; Lemos P.A.; Disco C.M.C.; Serruys P.W.

Research results: Balancing access with relevance for patient decisions
pp. 2450-2452(3)
Author: Lyles A.

Application of a data-mining technique to analyze coprescription patterns for antacids in Taiwan
pp. 2453-2463(11)
Authors: Chen T.-J.; Chou L.-F.; Hwang S.-J.

Cost-effectiveness of transfusion of platelet components prepared with pathogen inactivation treatment in the United States
pp. 2464-2486(23)
Authors: Bell C.E.; Botteman M.F.; Gao X.; Weissfeld J.L.; Postma M.J.; Pashos C.L.; Triulzi D.; Staginnus U.